Fundamental analysis · SEC EDGAR · TTM through 31/03/2026
IQV · NYSE · Healthcare
Fundamental quality
61
out of 100
Source: SEC EDGAR · TTM through 31/03/2026
The score combines growth, profitability and financial strength. Here its profitability weighs in its favor, while its growth drags it down the most.
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2021 | $13,874M | $966M | $2,302M | $10,759M |
| 2022 | $14,410M | $1,091M | $1,586M | $11,531M |
| 2023 | $14,984M | $1,358M | $1,500M | $12,297M |
| 2024 | $15,405M | $1,373M | $2,114M | $12,281M |
| 2025 | $16,310M | $1,360M | $2,051M | $13,744M |
Between 2021 and 2025, revenue went from $13,874M to $16,310M (+18%) and net income went from $966M to $1,360M (+41%).
Annual figures in U.S. dollars per SEC filings. Net debt is total debt minus cash.
Is Iqvia Holdings Inc. a profitable company?
Iqvia Holdings Inc. is profitable, with a net margin of 8.3%, though a thin one.
Does Iqvia Holdings Inc. have a lot of debt?
Yes, its leverage is high: net debt is 4.12 times its EBITDA.
Is Iqvia Holdings Inc. growing?
Its revenue has grown 4.5% annualized in recent years and its earnings per share 11.1%.
Does Iqvia Holdings Inc. generate cash?
Yes. It converts about 12.7% of its revenue into free cash flow.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
Is Iqvia Holdings Inc. cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Brokers you can use to invest in U.S. and European stocks.
The serious investor's standard →
Popular in the U.S. →
Other analyses
NVIDIA (NVDA) · Microsoft (MSFT) · Apple (AAPL) · Alphabet (Google) (GOOGL) · Amazon (AMZN) · Meta Platforms (META) · see more →